These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
368 related articles for article (PubMed ID: 35357458)
1. Off-Label Use of Tenecteplase for the Treatment of Acute Ischemic Stroke: A Systematic Review and Meta-analysis. Katsanos AH; Psychogios K; Turc G; Sacco S; de Sousa DA; De Marchis GM; Palaiodimou L; Filippou DK; Ahmed N; Sarraj A; Menon BK; Tsivgoulis G JAMA Netw Open; 2022 Mar; 5(3):e224506. PubMed ID: 35357458 [TBL] [Abstract][Full Text] [Related]
2. Intravenous Thrombolysis With Tenecteplase in Patients With Large Vessel Occlusions: Systematic Review and Meta-Analysis. Katsanos AH; Safouris A; Sarraj A; Magoufis G; Leker RR; Khatri P; Cordonnier C; Leys D; Shoamanesh A; Ahmed N; Alexandrov AV; Tsivgoulis G Stroke; 2021 Jan; 52(1):308-312. PubMed ID: 33272127 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety outcomes of Tenecteplase versus Alteplase for thrombolysis of acute ischemic stroke: A meta-analysis of 9 randomized controlled trials. Wang Y; Cai X; Fang Q; Zhu J J Neurol Sci; 2024 Mar; 458():122912. PubMed ID: 38325064 [TBL] [Abstract][Full Text] [Related]
4. Symptomatic Intracranial Hemorrhage With Tenecteplase vs Alteplase in Patients With Acute Ischemic Stroke: The Comparative Effectiveness of Routine Tenecteplase vs Alteplase in Acute Ischemic Stroke (CERTAIN) Collaboration. Warach SJ; Ranta A; Kim J; Song SS; Wallace A; Beharry J; Gibson D; Cadilhac DA; Bladin CF; Kleinig TJ; Harvey J; Palanikumar L; Doss VT; Marescalco R; Fink JN; Tyson A; Schlick KH; Noh L; Wilson D; Figueroa S; Pech MA; Paletz LB; Lewis MK; Castro M; Sahlein DH; Lafranchise EF; Sandall J; Asif KS; Geraghty SR; Cullis PA; Malisch T; Neill TA; LaMonte MP; Campbell BCV; Wu TY JAMA Neurol; 2023 Jul; 80(7):732-738. PubMed ID: 37252708 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of tenecteplase in comparison to alteplase in acute ischemic stroke: A systematic review and meta-analysis of randomized controlled trials. Salamatullah HK; Bashrahil B; Alghamdi AM; Alsharm FS; Alkulli OA; Alzahrani Z; Alkhiri A; Alghamdi S; Makkawi S Clin Neurol Neurosurg; 2023 Oct; 233():107961. PubMed ID: 37713743 [TBL] [Abstract][Full Text] [Related]
6. The efficacy and safety of intravenous thrombolysis with tenecteplase versus alteplase for acute ischemic stroke: a systematic review and meta-analysis. Wei H; Fu B; Yang C; Huang M Neurol Sci; 2023 Sep; 44(9):3005-3015. PubMed ID: 37061572 [TBL] [Abstract][Full Text] [Related]
7. Complications of Intravenous Tenecteplase Versus Alteplase for the Treatment of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis. Rose D; Cavalier A; Kam W; Cantrell S; Lusk J; Schrag M; Yaghi S; Stretz C; de Havenon A; Saldanha IJ; Wu TY; Ranta A; Barber PA; Marriott E; Feng W; Kosinski AS; Laskowitz D; Poli S; Mac Grory B Stroke; 2023 May; 54(5):1192-1204. PubMed ID: 36951049 [TBL] [Abstract][Full Text] [Related]
8. Intravenous Thrombolysis with Tenecteplase for the Treatment of Acute Ischemic Stroke. Tsivgoulis G; Katsanos AH; Christogiannis C; Faouzi B; Mavridis D; Dixit AK; Palaiodimou L; Khurana D; Petruzzellis M; Psychogios K; Macleod MJ; Ahmed N Ann Neurol; 2022 Sep; 92(3):349-357. PubMed ID: 35713213 [TBL] [Abstract][Full Text] [Related]
9. Tenecteplase versus alteplase for management of acute ischemic stroke: a pairwise and network meta-analysis of randomized clinical trials. Kheiri B; Osman M; Abdalla A; Haykal T; Ahmed S; Hassan M; Bachuwa G; Al Qasmi M; Bhatt DL J Thromb Thrombolysis; 2018 Nov; 46(4):440-450. PubMed ID: 30117036 [TBL] [Abstract][Full Text] [Related]
10. Tenecteplase vs. alteplase for the treatment of patients with acute ischemic stroke: a systematic review and meta-analysis. Ma P; Zhang Y; Chang L; Li X; Diao Y; Chang H; Hui L J Neurol; 2022 Oct; 269(10):5262-5271. PubMed ID: 35776193 [TBL] [Abstract][Full Text] [Related]
11. Tenecteplase versus alteplase for acute ischemic stroke: a systematic review and meta-analysis of randomized and non-randomized studies. Ma Y; Xiang H; Busse JW; Yao M; Guo J; Ge L; Li B; Luo X; Mei F; Liu J; Wang Y; Liu Y; Li W; Zou K; Li L; Sun X J Neurol; 2024 May; 271(5):2309-2323. PubMed ID: 38436679 [TBL] [Abstract][Full Text] [Related]
12. Evidence that Tenecteplase Is Noninferior to Alteplase for Acute Ischemic Stroke: Meta-Analysis of 5 Randomized Trials. Burgos AM; Saver JL Stroke; 2019 Aug; 50(8):2156-2162. PubMed ID: 31318627 [TBL] [Abstract][Full Text] [Related]
13. Tenecteplase vs. alteplase for treatment of acute ischemic stroke: A systematic review and meta-analysis of randomized trials. Kobeissi H; Ghozy S; Turfe B; Bilgin C; Kadirvel R; Kallmes DF; Brinjikji W; Rabinstein AA Front Neurol; 2023; 14():1102463. PubMed ID: 36756249 [TBL] [Abstract][Full Text] [Related]
14. Different doses of tenecteplase vs alteplase in thrombolysis therapy of acute ischemic stroke: evidence from randomized controlled trials. Xu N; Chen Z; Zhao C; Xue T; Wu X; Sun X; Wang Z Drug Des Devel Ther; 2018; 12():2071-2084. PubMed ID: 30013325 [TBL] [Abstract][Full Text] [Related]
15. Tenecteplase versus alteplase for patients with acute ischemic stroke: a meta-analysis of randomized controlled trials. Zhang X; Wan TF; Chen J; Liu L Aging (Albany NY); 2023 Dec; 15(24):14889-14899. PubMed ID: 38149983 [TBL] [Abstract][Full Text] [Related]
16. The efficacy and safety of tenecteplase versus alteplase for acute ischemic stroke: an updated systematic review, pairwise, and network meta-analysis of randomized controlled trials. Abuelazm M; Seri AR; Awad AK; Ahmad U; Mahmoud A; Albazee E; Kambalapalli S; Abdelazeem B J Thromb Thrombolysis; 2023 Feb; 55(2):322-338. PubMed ID: 36449231 [TBL] [Abstract][Full Text] [Related]
17. Routine Use of Tenecteplase for Thrombolysis in Acute Ischemic Stroke. Zhong CS; Beharry J; Salazar D; Smith K; Withington S; Campbell BCV; Wilson D; Le Heron C; Mason D; Duncan R; Reimers J; Mein-Smith F; Diprose WK; Barber PA; Ranta A; Fink JN; Wu TY Stroke; 2021 Mar; 52(3):1087-1090. PubMed ID: 33588597 [TBL] [Abstract][Full Text] [Related]
18. Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial. Wang Y; Li S; Pan Y; Li H; Parsons MW; Campbell BCV; Schwamm LH; Fisher M; Che F; Dai H; Li D; Li R; Wang J; Wang Y; Zhao X; Li Z; Zheng H; Xiong Y; Meng X; Lancet; 2023 Feb; 401(10377):645-654. PubMed ID: 36774935 [TBL] [Abstract][Full Text] [Related]
19. Tenecteplase vs. Alteplase for Intravenous Thrombolytic Therapy of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis. Shen Z; Bao N; Tang M; Yang Y; Li J; Liu W; Jiang G Neurol Ther; 2023 Oct; 12(5):1553-1572. PubMed ID: 37552459 [TBL] [Abstract][Full Text] [Related]
20. Intravenous thrombolysis with tenecteplase versus alteplase combined with endovascular treatment of anterior circulation tandem occlusions: A pooled analysis of ETIS and TETRIS. Marnat G; Lapergue B; Gory B; Kyheng M; Labreuche J; Turc G; Olindo S; Sibon I; Caroff J; Smadja D; Chausson N; Clarençon F; Seners P; Bourcier R; Pop R; Olivot JM; Mazighi M; Moulin S; Janot K; Cognard C; Alamowitch S; Gerschenfeld G Eur Stroke J; 2024 Mar; 9(1):124-134. PubMed ID: 37837202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]